BCL2 and myeloid sarcoma: In addition, animal models of MS that received PBM treatment exhibited up-regulation of the Bcl-2 anti-apoptosis gene, an increased Bcl-2: Bax ratio, and reduced apoptosis in the spinal cord (30).